Combination therapy

Results: 292



#Item
231Patients at high-immunologic risk 	 Rapamune and Cyclosporine Combination Therapy (for the first 12 months post-transplantation): One loading dose of up to 15 mg on day 1, followed by daily maintenance doses of 5 mg (

Patients at high-immunologic risk  Rapamune and Cyclosporine Combination Therapy (for the first 12 months post-transplantation): One loading dose of up to 15 mg on day 1, followed by daily maintenance doses of 5 mg (

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-02-04 16:31:08
232Urology Times ® The Leading News Source for Urologists  Vol. 32, No. 10

Urology Times ® The Leading News Source for Urologists Vol. 32, No. 10

Add to Reading List

Source URL: www.prostatitis.org

Language: English - Date: 2015-02-13 15:50:26
233Cancer pain is caused by the cancer itself, the treatments being used, or a combination of both. Major causes of pain come from: medical tests, tumors, spinal cord compression, treatment: chemotherapy, radiation, neuropa

Cancer pain is caused by the cancer itself, the treatments being used, or a combination of both. Major causes of pain come from: medical tests, tumors, spinal cord compression, treatment: chemotherapy, radiation, neuropa

Add to Reading List

Source URL: www.lifewithcancer.org

Language: English - Date: 2012-08-14 00:24:38
2342012 National Ambulatory Medical Care Survey Asthma Supplement

2012 National Ambulatory Medical Care Survey Asthma Supplement

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2013-06-26 08:34:09
235U.S. Fire Administration  Health and Wellness Guide for the Volunteer Fire and Emergency Services FA-321/February 2009

U.S. Fire Administration Health and Wellness Guide for the Volunteer Fire and Emergency Services FA-321/February 2009

Add to Reading List

Source URL: www.nvfc.org

Language: English - Date: 2012-12-06 15:07:49
236HIGHLIGHTS OF PRESCRIBING INFORMATION  • These highlights do not include all the information needed to use DULERA safely and effectively. See full prescribing information for

HIGHLIGHTS OF PRESCRIBING INFORMATION • These highlights do not include all the information needed to use DULERA safely and effectively. See full prescribing information for

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-08-24 15:16:10
237Escalation Strategies for Combination Therapy Phase I Trials Michael Sweeting1 and Adrian Mander2 1  Cardiovascular Epidemiology Unit, University of Cambridge

Escalation Strategies for Combination Therapy Phase I Trials Michael Sweeting1 and Adrian Mander2 1 Cardiovascular Epidemiology Unit, University of Cambridge

Add to Reading List

Source URL: www.rss.org.uk

Language: English - Date: 2014-03-31 05:06:22
    238FDA Presentation Advair Diskus[removed]

    FDA Presentation Advair Diskus[removed]

    Add to Reading List

    Source URL: www.fda.gov

    Language: English - Date: 2009-01-05 11:05:16
    239CANADIAN NETWORK FOR RESPIRATORY CARE SPECIAL SUPPLEMENT • SUMMER[removed]TAKE YOUR MEDICATION ON VACATION BY KRISTINA BERGEN

    CANADIAN NETWORK FOR RESPIRATORY CARE SPECIAL SUPPLEMENT • SUMMER[removed]TAKE YOUR MEDICATION ON VACATION BY KRISTINA BERGEN

    Add to Reading List

    Source URL: cnrchome.net

    Language: English - Date: 2010-10-06 12:02:54
    240Discussion of benefits in the context of risks of LABAs for the treatment of asthma

    Discussion of benefits in the context of risks of LABAs for the treatment of asthma

    Add to Reading List

    Source URL: www.fda.gov

    Language: English - Date: 2009-01-05 11:05:20